Research
2006
Centre for Drug Design and Discovery - CD3 LeuvenCD3 Leuven, or the Centre for Drug Design and Discovery, is an investment fund and drug discovery center in Leuven, Belgium, dedicated to translating innovative biomedical research into new medicines. It bridges the gap between academic research and the pharmaceutical industry, investing in projects, developing drugs, and partnering with biotechs and pharma companies.
Here's a more detailed breakdown:
Investment Fund:
CD3 invests in early-stage drug discovery projects, spin-off companies, and biotechs, providing financial support for bringing promising research to the clinic.
Drug Discovery Center:
CD3 complements its investments with a drug discovery team and infrastructure to validate research, develop potential drug candidates, and bring them closer to clinical trials.
Collaboration:
A core function of CD3 is collaborating with academic research groups and biotech companies, leveraging their expertise and innovative science.
Technology Transfer:
CD3 facilitates the transfer of innovative research from universities and academic institutions into the pharmaceutical industry, ultimately benefiting patients.
Goal:
The ultimate goal of CD3 is to discover and develop new medicines that can be used to treat various diseases, working closely with pharmaceutical companies to bring these drugs to market.
Here's a more detailed breakdown:
Investment Fund:
CD3 invests in early-stage drug discovery projects, spin-off companies, and biotechs, providing financial support for bringing promising research to the clinic.
Drug Discovery Center:
CD3 complements its investments with a drug discovery team and infrastructure to validate research, develop potential drug candidates, and bring them closer to clinical trials.
Collaboration:
A core function of CD3 is collaborating with academic research groups and biotech companies, leveraging their expertise and innovative science.
Technology Transfer:
CD3 facilitates the transfer of innovative research from universities and academic institutions into the pharmaceutical industry, ultimately benefiting patients.
Goal:
The ultimate goal of CD3 is to discover and develop new medicines that can be used to treat various diseases, working closely with pharmaceutical companies to bring these drugs to market.
Address
Gaston Geenslaan 2, 3001 Leuven, Belgium